Suppr超能文献

尼提亚·阿南德博士:“萨赫利”背后的有远见者与药物化学的进展。

Dr. Nitya Anand: The Visionary Behind Saheli and the Advances in Medicinal Chemistry.

作者信息

Singh Anshu, Kawalkar Umesh, Mankar Amar, Patil Manoj S

机构信息

Community Medicine, Government Medical College (GMC) Akola, Akola, IND.

Community Medicine, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

出版信息

Cureus. 2024 Aug 30;16(8):e68208. doi: 10.7759/cureus.68208. eCollection 2024 Aug.

Abstract

Dr. Nitya Anand was a leading figure in Indian pharmaceutical research. His career spanned several decades, during which he significantly contributed to advancement in drug development and public health. His innovation of Centchroman (Saheli), the world's first non-steroidal oral contraceptive pill, changes the course of contraception use in India. He had done groundbreaking work in leprosy treatment, synthetic peptides, and antibiotics. With over 400 publications and 130 patents, he supervised over 100 PhD students. His work has been recognized with many prestigious awards, including the Padma Shri and the National Nehru Science Award, which have left a long-lasting impact on medicinal chemistry and public health.

摘要

尼提亚·阿南德博士是印度制药研究领域的领军人物。他的职业生涯跨越了几十年,在此期间,他为药物开发和公共卫生的进步做出了重大贡献。他研发的世界上第一种非甾体口服避孕药Centchroman(萨赫利),改变了印度避孕药具的使用进程。他在麻风病治疗、合成肽和抗生素方面都做了开创性的工作。他发表了400多篇论文,拥有130项专利,指导了100多名博士生。他的工作获得了许多 prestigious awards,包括Padma Shri和国家尼赫鲁科学奖,这些奖项对药物化学和公共卫生产生了持久的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ce/11439483/6643995472d4/cureus-0016-00000068208-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验